Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Cerilliant
Daiichi Sankyo
Cantor Fitzgerald
Medtronic
Baxter
UBS
Fuji
AstraZeneca

Generated: April 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205739

« Back to Dashboard

NDA 205739 describes VELTASSA, which is a drug marketed by Relypsa Inc and is included in one NDA. It is available from one supplier. There are ten patents protecting this drug. Additional details are available on the VELTASSA profile page.

The generic ingredient in VELTASSA is patiromer sorbitex calcium. One supplier is listed for this compound. Additional details are available on the patiromer sorbitex calcium profile page.
Summary for 205739
Tradename:VELTASSA
Applicant:Relypsa Inc
Ingredient:patiromer sorbitex calcium
Patents:10
Pharmacology for NDA: 205739
Suppliers and Packaging for NDA: 205739
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VELTASSA patiromer sorbitex calcium POWDER;ORAL 205739 NDA Relypsa, Inc. 53436-084 N 53436-084-04
VELTASSA patiromer sorbitex calcium POWDER;ORAL 205739 NDA Relypsa, Inc. 53436-084 N 53436-084-30

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;ORALStrengthEQ 8.4GM BASE/PACKET
Approval Date:Oct 21, 2015TE:RLD:Yes
Regulatory Exclusivity Expiration:Oct 21, 2020
Regulatory Exclusivity Use:NEW CHEMICAL ENTITY
Patent:➤ Sign UpPatent Expiration:Feb 27, 2025Product Flag?Substance Flag?Delist Request?
Patented Use:TREATMENT OF HYPERKALEMIA
Patent:➤ Sign UpPatent Expiration:Mar 11, 2026Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Teva
Cantor Fitzgerald
Argus Health
Covington
Express Scripts
US Army
Medtronic
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.